Davis Polk – Davis Polk advised J.P. Morgan Securities LLC and Goldman, Sachs & Co. as joint book-running managers in connection with the initial public offering of 8,050,000 shares of common stock of ZELTIQ Aesthetics, Inc. The gross proceeds from the offering were approximately $104.7 million. ZELTIQ’s common stock is traded on the Nasdaq Global Select Market under the symbol “ZLTQ.”
Based in Pleasanton, California, ZELTIQ Aesthetics, Inc. is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ’s first commercial product, the CoolSculpting® System, is designed to selectively reduce stubborn fat bulges that may not respond to diet or exercise.
The Davis Polk corporate team included partner Alan F. Denenberg and associates Beth Hooton Ruiz and Daniel J. Luskin. Partner Rachel D. Kleinberg and associate Una Au provided tax advice. Counsel Loyti Cheng and associate Ona Oshen provided environmental advice. Counsel Cynthia Akard provided employment advice. Counsel Marcie A. Goldstein provided FINRA advice. Associates Emma Maconick and Daniel Ray provided intellectual property advice. Elizabeth J. Gordon was the legal assistant for the transaction. Members of the Davis Polk team are based in the Menlo Park and New York offices.
